drugset / Trial / NCT00648271
Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's metoprolol tartrate tablets to Novartis' Lopressor® tablets following a single, oral 50 mg (2 x 25 mg tablets for Mylan's formulation and 1 x 50 mg for Lopressor®) dose administered under fed conditions.
Timeline
- Start
- 2002-12
- Primary completion
- 2002-12
- Completion
- 2003-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.